CHICAGO, IL, USA I June 2, 2025 I ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial ...

Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral ...

While oesophageal cancer data by histology were relatively complete, it represented a clear challenge for stomach cancer, where on average 49% of all cancers were categorised as overlapping or ...

Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related deaths worldwide due to lack of effective diagnosis at early stages and limited comprehension of its pathogenesis, thus ...

This is the highest reported objective response rate of any systemic treatment in unresectable hepatocellular carcinoma, surpassing atezolizumab–bevacizumab (30%) 11 and STRIDE (20%). 13 However, this ...

Objective To evaluate the relationship between the absorbed dose and radiological response in patients with hepatocellular carcinoma undergoing resin microsphere radioembolization to enhance treatment ...

Patients with other cancer diagnoses within 5 years of PHL diagnosis and non-hepatic primary lymphoma were excluded. Subgroup analysis was performed for two histologic subgroups: diffuse large B-cell ...

HIV associated hepatocellular cancer (HCC) in an inner-city minority population. The impact of sorafenib on the treatment and survival of advanced hepatocellular carcinoma (HCC): Analysis of the ...

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer ... and the Brazilian Society of Pathology (SBP). The purpose of this document was to assist healthcare professionals, ...